author-photo

Stephen T. Keir

Duke University

200

Papers

12130

Citations

Citation Trend

Filter By

Papers (137) Sort By

Journal Conference Others

A Modified Nucleoside 6-thio-2'-deoxyguanosine Exhibits Anti-tumor Activity in Gliomas.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 5821: The role of SMARCAL1 loss-of-function mutations in glioblastoma telomere maintenance

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
TMOD-27. EFFICACY OF SOLUBLE PANOBINOSTAT (MTX110) IN PRECLINICAL MODELS OF ADULT GLIOBLASTOMA

2020 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
IMMU-18. INTERPLAY BETWEEN IDH1 AND ATRX MUTATIONS GOVERN INNATE IMMUNE RESPONSES IN GLIOMAS

2020 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
MTAP loss promotes stemness in glioblastoma and confers unique susceptibility to purine starvation

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (17)
Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors

2019 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (10)
Bevacizumab, irinotecan, temozolomide, tyrosine kinase inhibition, and MEK inhibition are effective against pleomorphic xanthoastrocytoma regardless of V600E status

2018 Journal of Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (6)
A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma

2018 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (25)
Immunotoxin and bcl-2 inhibitor combination therapy targeting chondroitin sulfate proteoglycan 4.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
TMOD-33. ESTABLISHMENT AND PRELIMINARY EVALUATION OF BEVACIZUMAB-RESISTANT GLIOMA XENOGRAFT MODELS

2018 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)